Cullinan Oncology Inc.

8.37
-0.12 (-1.41%)
At close: Mar 03, 2025, 11:40 AM

Cullinan Oncology Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a 18.94M n/a n/a n/a
Cost of Revenue 310K 93K 53K 62K 70K 43K
Gross Profit -310K -93K 18.89M -62K -70K -43K
Operating Income -191.09M 144.65M -67.95M -60.34M -22.27M -14.59M
Interest Income 21.63M 6.61M 477K 888K 620K 397K
Pretax Income -169.22M 151.32M -67.48M -59.46M -21.65M -14.19M
Net Income -153.16M 111.21M -65.04M -50.85M -20.04M -14.19M
Selling & General & Admin 42.49M 40.19M 29.15M 17.12M 5.48M 5M
Research & Development 148.16M 91.95M 57.75M 43.21M 16.79M 9.58M
Other Expenses 440K 57K -8K -11K -4K n/a
Operating Expenses 191.09M 132.14M 86.9M 60.34M 22.27M 14.59M
Interest Expense n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 191.09M 132.14M 86.9M 60.34M 22.27M 14.59M
Income Tax -14.12M 42.12M -2.44M -8.61M -1.62M 397K
Shares Outstanding (Basic) 41.51M 45.16M 44.29M 43.52M 43.52M 11.45M
Shares Outstanding (Diluted) 41.55M 46.64M 44.29M 43.52M 43.52M 11.45M
EPS (Basic) -3.69 2.46 -1.47 -1.17 -0.46 -1.24
EPS (Diluted) -3.69 2.38 -1.47 -1.17 -0.46 -1.24
EBITDA -190.34M 151.41M -67.9M -60.27M -22.2M -14.54M
Depreciation & Amortization 310K 93K 53K 62K 70K 43K